Health Care & Life Sciences » Biotechnology | Gilead Sciences Inc.

Gilead Sciences Inc.

Gilead Sciences Inc. BDR
Stock Exchange Brazilian Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
-
Public Float
-
Gilead Sciences Inc.
Stock Exchange Xetra Stock Exchange
EPS
EUR3.9
Market Cap
EUR78.15 B
Shares Outstanding
1.3 B
Public Float
1.3 B
Gilead Sciences Inc.
Stock Exchange Mexican Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
1.3 B
Public Float
1.3 B
Gilead Sciences Inc.
Stock Exchange NASDAQ Stock Market
EPS
$4.54
Market Cap
$87.14 B
Shares Outstanding
1.27 B
Public Float
1.27 B
Gilead Sciences Inc.
Stock Exchange SIX Swiss Exchange
EPS
-
Market Cap
-
Shares Outstanding
1.3 B
Public Float
1.3 B

Profile

Address
333 Lakeside Drive
Foster City California 94404
United States
Employees -
Website http://www.gilead.com
Updated 07/08/2019
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. It also offers other pharmaceutical products under the Letairis, Ranexa, AmBisome, and Zydelig brands.

Financials

View All

John C. Martin
Chairman
John F. Milligan
President, Chief Executive Officer & Director